Additionally, evidence from our previous study and others have demonstrated that serum EBV VCA-IgA, an indicator of EBV activation, preceded long before the development of NPC (31, 32), together highlighting the etiological role of continuous EBV reactivation in NPC development. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.